J Reconstr Microsurg 2013; 29(05): 297-302
DOI: 10.1055/s-0032-1333323
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Islanded Perforator Flaps in the Reconstruction of Hidradenitis Suppurativa Defects

Onur Egemen
1   Okmeydani Education and Research Hospital, Plastic and Reconstructive Surgery Clinic, Istanbul, Turkey
,
Özay Özkaya
1   Okmeydani Education and Research Hospital, Plastic and Reconstructive Surgery Clinic, Istanbul, Turkey
,
Derya Bingöl
1   Okmeydani Education and Research Hospital, Plastic and Reconstructive Surgery Clinic, Istanbul, Turkey
,
Çağdaş Orman
1   Okmeydani Education and Research Hospital, Plastic and Reconstructive Surgery Clinic, Istanbul, Turkey
,
Mithat Akan
1   Okmeydani Education and Research Hospital, Plastic and Reconstructive Surgery Clinic, Istanbul, Turkey
› Author Affiliations
Further Information

Publication History

15 September 2012

22 October 2012

Publication Date:
09 January 2013 (online)

Abstract

Hidradenitis suppurativa is a recurrent, chronic, and suppurative cutaneous disease of unknown etiology. Radical excision of all affected skin followed by flap coverage of the defect is the treatment method of choice in severe and recurrent cases. This study discusses the use of local islanded perforator flaps in the reconstruction of defects following excision of hidradenitis suppurativa lesions in axillary, gluteal, and inguinal regions. Eleven male patients (mean age of 39.3 years) underwent reconstruction of hidradenitis suppurativa defects with 13 local islanded perforator flaps. Three patients (one being bilateral) had gluteal, two patients (one being bilateral) had inguinal, and six patients had axillary involvement. The defects in the gluteal region were repaired with superior gluteal artery perforator flaps, inguinal defects were repaired with medial circumflex femoral artery perforator flaps, and the axillary defects were repaired with thoracodorsal artery perforator flaps. There was no total flap loss in the postoperative period, but one marginal necrosis and two wound infections occurred. There was no recurrence of hidradenitis suppurativa or revision requirement during the mean follow-up period of 11.5 months.

 
  • References

  • 1 Buimer MG, Wobbes T, Klinkenbijl JHG. Hidradenitis suppurativa. Br J Surg 2009; 96: 350-360
  • 2 Brown SC, Kazzazi N, Lord PH. Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perianal form. Br J Surg 1986; 73: 978-980
  • 3 Li EN, Mofid MM, Goldberg NH, Silverman RP. Surgical management of hidradenitis suppurativa of the nipple-areolar complex. Ann Plast Surg 2004; 52: 220-223
  • 4 Slade DEM, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg 2003; 56: 451-461
  • 5 Paletta C, Jurkiewicz MJ. Hidradenitis suppurativa. Clin Plast Surg 1987; 14: 383-390
  • 6 Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60: 539-561 , quiz 562–563
  • 7 Fitzsimmons JS, Guilbert PR, Fitzsimmons EM. Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol 1985; 113: 1-8
  • 8 Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol 2010; 62: 205-217
  • 9 Mortimer PS, Lunniss PJ. Hidradenitis suppurativa. J R Soc Med 2000; 93: 420-422
  • 10 Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach. In: Roenigk RK, Roenigk Jr HH, , eds. Dermatologic Surgery. Principles and Practice. New York: Marcel Dekker Inc.; 1996: 623-645
  • 11 Pedraz J, Daudén E. [Practical management of hidradenitis suppurativa]. Actas Dermosifiliogr 2008; 99: 101-110
  • 12 Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 1983; 22: 325-328
  • 13 Jemec GBE, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998; 39: 971-974
  • 14 Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2009; 23: 985-998
  • 15 van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol 2010; 63: 475-480
  • 16 Kagan RJ, Yakuboff KP, Warner P, Warden GD. Surgical treatment of hidradenitis suppurativa: a 10-year experience. Surgery 2005; 138: 734-740 , discussion 740–741
  • 17 Tanaka A, Hatoko M, Tada H, Kuwahara M, Mashiba K, Yurugi S. Experience with surgical treatment of hidradenitis suppurativa. Ann Plast Surg 2001; 47: 636-642
  • 18 Soldin MG, Tulley P, Kaplan H, Hudson DA, Grobbelaar AO. Chronic axillary hidradenitis—the efficacy of wide excision and flap coverage. Br J Plast Surg 2000; 53: 434-436
  • 19 Parks RW, Parks TG. Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl 1997; 79: 83-89
  • 20 Rieger UM, Erba P, Pierer G, Kalbermatten DF. Hidradenitis suppurativa of the groin treated by radical excision and defect closure by medial thigh lift: aesthetic surgery meets reconstructive surgery. J Plast Reconstr Aesthet Surg 2009; 62: 1355-1360
  • 21 Hynes PJ, Earley MJ, Lawlor D. Split-thickness skin grafts and negative-pressure dressings in the treatment of axillary hidradenitis suppurativa. Br J Plast Surg 2002; 55: 507-509
  • 22 Chen E, Friedman HI. Management of regional hidradenitis suppurativa with vacuum-assisted closure and split thickness skin grafts. Ann Plast Surg 2011; 67: 397-401
  • 23 Banarjee AK. Surgical treatment of hidradenitis suppurativa. Br J Plast Surg 1992; 79: 863-866
  • 24 Varkarakis G, Daniels J, Coker K, Oswald T, Akdemir O, Lineaweaver WC. Treatment of axillary hidradenitis with transposition flaps: a 6-year experience. Ann Plast Surg 2010; 64: 592-594
  • 25 Kishi K, Nakajima H, Imanishi N, Nakajima T. Extended split superior gluteus maximus musculocutaneous flap and reconstruction after resection of perianal and lower gluteal hidradenitis suppurativa. J Plast Reconstr Aesthet Surg 2009; 62: 1081-1086
  • 26 Gorkisch K, Boese-Landgraf J, Vaubel E. [Hidradenitis suppurativa—treatment with myocutaneous island flap or the traditional method]. Handchir Mikrochir Plast Chir 1984; 16: 135-138
  • 27 Kishi K, Nakajima H, Imanishi N. Reconstruction of skin defects after resection of severe gluteal hidradenitis suppurativa with fasciocutaneous flaps. J Plast Reconstr Aesthet Surg 2009; 62: 800-805
  • 28 Mun GH, Jo YW, Lim SY, Hyon WS, Bang SI, Oh KS. Pedicled perforator flap of stellate design. J Plast Reconstr Aesthet Surg 2008; 61: 1332-1337
  • 29 Saint-Cyr M, Wong C, Schaverien M, Mojallal A, Rohrich RJ. The perforasome theory: vascular anatomy and clinical implications. Plast Reconstr Surg 2009; 124: 1529-1544
  • 30 Taylor GI, Corlett RJ, Dhar SC, Ashton MW. The anatomical (angiosome) and clinical territories of cutaneous perforating arteries: development of the concept and designing safe flaps. Plast Reconstr Surg 2011; 127: 1447-1459
  • 31 Geh JLC, Niranjan NS. Perforator-based fasciocutaneous island flaps for the reconstruction of axillary defects following excision of hidradenitis suppurativa. Br J Plast Surg 2002; 55: 124-128
  • 32 Rehman N, Kannan RY, Hassan S, Hart NB. Thoracodorsal artery perforator (TAP) type I V-Y advancement flap in axillary hidradenitis suppurativa. Br J Plast Surg 2005; 58: 441-444
  • 33 Unal C, Yirmibesoglu OA, Ozdemir J, Hasdemir M. Superior and inferior gluteal artery perforator flaps in reconstruction of gluteal and perianal/perineal hidradenitis suppurativa lesions. Microsurgery 2011; 31: 539-544